Totus Medicines names new chair of company's board of directors
6 May 2022 -

Totus Medicines, a US-based drug discovery company, announced on Thursday that it has named Tom Hughes, PhD as the chair of the company's board of directors.

Presently, Dr Hughes serves as president and CEO of Navitor Pharmaceuticals. He has more than 30 years of industry experience in the development and commercialisation of pharmaceutical products. He has held the position of CEO of Zafgen and several positions at Novartis. He is also a member of the board of directors of Viridian Therapeutics, Inc., and serves as a member of several other scientific and strategic advisory boards.

Totus CEO and founder Dr Neil Dhawan, PhD, said, 'Dr. Hughes's extraordinary breadth of experience makes him the perfect choice to lead our board -- his knowledge of the industry is unparalleled, and he has led many projects that brought life-saving treatments to the public. We couldn't be more thrilled that he is joining our team as we move forward in bringing TOS-358 to the clinic later this year.'